User:Help turnitin

1. Lip G, Gibbs C. Does Heart failure confer a hypercoagulable state? Virchow´s triad revisited. JACC 1999;33:1424–1426. 2. Kubo S, Rectoe T, Bank A, Williams R, Heifetz S. Endothelium dependent vasodilatation is attenuated in patients with Heart failure. Circulation 1991;84:1589-96. 3. Ikeda U,Yamamoto K, Shimada K. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation and cardiomiopathy. Clin Cardiol 1997;20:7-10. 4. Jung S, Wilensky R, Zeller J, Sawada S. Thrombin activation in dilated cardiomyopathy. JACC 1993;21:311A. 5. O Connor C, Curbel P, Serebruany V. Usefulness of soluble and surface bound P selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol 1999;83:1345-99. 6. Spodick D, Littmann D. Idiopathic myocardial hypertrophy. Am J Cardiol 1958;1:610-23. 7. Roberts W, Siegal R, McManus B. Idiopathic dilated cardiomyopathy:analysis of 152 necropsy patients. Am J Cardiol 1987;60:1340-55. 8. Fuster V, Gersh B, Guiliani E, Tajik A, Brandenburg R, Frye R. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-530. 9. Natterson P, Stevenson W, Saxon L, Middlekauff H, Stevenson L. Risk of arterial embolization in 224 patients awaiting cardiac transplantation. Am Heart J 1995;129:564-570. 10. Sharma N, McCullough P, Philbin E, Weaver W. Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest 2000;117:314-320. 11. Dunkman W, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. Incidence of thromboembolic events in congestive heart failure. Circulation 1993;87 (suppl 6):VI94-VI101. 12. Pfeffer M, Braunwald E, Moye L, Basta L, Brown E, Cuddy T, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. NEJM 1992; 327:699-77. 13. Dries D, Rosenberg Y, Waclawiw M, Domanski m. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhytm: evidence for gender differences in the Studies of Left Ventricular Dysfunction trial. JACC 1997;29:1074-1080. 14. Harrington R. Antithrombotic therapy in coronary artery disease. Chest 2004;126:513-548. 15. Al-Khadra A, Salem D, Rand W, Udelson J, Smith J, Konstam M. Warfarin anticoagulation and survival : a cohort analysis from studies of left ventricular dysfunction. JACC 1998;31:749-53. 16. Cleland J, Finclay M, Jafri S, Suttonm M, Falk M, Bulpitt M, et al. The warfarin aspirin study in heart failure (WASH) a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004;148:157-64. 17. Teo K, Yusuf S, Pfeffer M, et al. Effects of long term treatment with ACE inhibitors in the presence or absence of aspirin: a systematic review. Lancet 2002; 360:1037-1043.